
MBO Partenaires takes 70% stake in Cosmogen
MBO Partenaires has backed the management buyout of cosmetics packaging and applicators producer Cosmogen, taking a 70% stake in the group.
The group's management team, led by Renaud van den Berg, will stay on as minority shareholders.
The transaction comes two years after MBO Partenaires had taken a 51% controlling stake in Groupe Alkos through an MBO.
The GP has now reduced its stake in Alkos, enabling founder Gérard Gieux to re-increase his share.
With Cosmogen, the GP will now focus on establishing new partnerships with international brands in the cosmetics industry, including L'Oréal, Dior, Yves Saint Laurent, Estée Lauder, and more. Cosmogen currently operates in China, Brazil, the US and Latin America and plans to continue its international expansion.
Debt
A two-tranche senior debt package provided by Banque Populaire Val-de-France, LCL and CIC supported the transaction.
Previous funding
In 2008, BPI France, alongside Qualium Investissement and NCI Gestion, took a 24% minority stake in Alkos Cosmétiques via the holding vehicle Alkos Développement. Gérard Gieux, who has been leading the company since 1996, held the remaining 76% stake. The investment was used to finance the acquisition of Inter Cosmétiques and Sagal.
In 2014, MBO Partenaires took a majority 51% stake in the group through an MBO, leaving founder Gérard Gieux with a minority stake. The deal also saw Dominique Vautier acquire a minority stake in the group and become Alkos's CEO, replacing Gieux. Previous backers BPI, NCI and Qualium exited the group on this occasion.
Company
Created in 1982, Cosmogen is specialised in the design and manufacturing of packaging and applicators for cosmetics, and of brushes and accessories. The group currently registers €26m in revenues, half of which is generated abroad, with 20% in Latin America only.
Alkos is based in Boulogne-sur-Mer. The company's roots date back over 200 years when it was a part of Faber-Comté. It was bought in distress in 1996 by Gérard Gieux and started operating under the Alkos Cosmétiques brand.
The company develops and produces make-up products, principally eye liner and lip liner. The acquisitions of Inter Cosmétiques and Sagal, based in Angers and Gaillardon respectively, enabled the company to expand into three new market segments: corporal hygiene, corporal health and make-up. Following the acquisitions, the group rebranded as Groupe Alkos.
The combined entity Alkos/Cosmogen, based in Paris, currently generates a €77m turnover.
Advisers
Equity – Finexsi, Erick Uzzan (financial due diligence); Lamartine Conseil, Olivier Renault, Bintou Niang, Vanessa Placerdat, Nicolas Cuchet (legal); EY, Mathias Roth, Alex Larue (corporate finance).
Vendor – Societex Corporate Finance, Bernard Maussion (corporate finance).
Debt – Agilys Avocats, Frédéricque Milotic (legal).
People
MBO Partenaires – Gabriel Nectoux (senior associate).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater